ADSTILADRIN

Medicinal product

(Invented) name

ADSTILADRIN

Active substance (s)

Nadofaragenas firadenovekas

Strength

3×10(×11) vd/ml

Pharmaceutical form

šlapimo pūslės suspensija

Route (s) of administration

vartoti į šlapimo pūslę

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

L01XL10, nadofaragene firadenovec

Marketing authorisation holder

Ferring Pharmaceuticals A/S, Danija

Date of authorisation

2026-05-28

Date of renewal

Documents

Search in EMA Europe

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

1 ml suspensijos yra:	1 ml
Nadofaragenas firadenovekas	3×10(×11) vd/ml

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
121335	107443	1107443	flakonas	20 ml N4		Receptinis	EU/1/26/2035/001	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2026-05-28	Registruotas